Uni-Bio Science Group Announces 2020 Interim Results
Operating Profit From Marketed Pharmaceutical Products Recorded an Increase of 126.6% Expanding R&D Activity in Antibody Drug Development to Diversify Product Portfolio HONG KONG, CHINA – EQS Newswire – 28 August 2020 – A fully integrated biopharmaceutical company — Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred to as the “Group”, stock code: 0690.HK), is pleased to announce its interim results for six months ended […]